NASDAQ: IVF · Industrial Applications and Services · 3 alerts · CIK 1417926
Share price
$2.40Close, Nov 16
Market cap
$2.86M
Shares outstanding
1.19MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Invo Fertility, Inc. filings on SEC EDGAR ↗
INVO Fertility reported Q3 2026 financial results featuring a 26% increase in total revenue to $2.2 million and a 28% growth in clinic-specific revenue. The company narrowed its net loss to $2.1 million and achieved its seventh consecutive quarter of positive clinic-level Adjusted EBITDA while significantly reducing liabilities by $5.5 million compared to year-end 2025.
INVO Fertility, Inc. reported total revenue of $6.41 million for the nine months ended September 30, 2026, a 22% increase over the prior year, primarily driven by clinic revenue growth. Despite the revenue increase, the company realized a net loss from continuing operations of $6.71 million, impacted by significant non-cash items including a $4.35 million loss on the change in fair value of derivatives.
INVO Fertility, Inc. implemented a 1-for-4 reverse stock split of its issued, outstanding, and authorized common stock effective October 30, 2026. The split reduced the number of outstanding shares to approximately 1.2 million and adjusted the authorized share count to 62.5 million to maintain compliance with Nasdaq listing requirements. Trading commenced on a split-adjusted basis under the existing symbol 'IVF' with a new CUSIP number.